Lung Injury Center, Section of Pulmonary and Critical Medicine, Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA.
J Biol Chem. 2013 Jun 21;288(25):18290-9. doi: 10.1074/jbc.M112.432757. Epub 2013 May 7.
p120-catenin is a multidomain intracellular protein, which mediates a number of cellular functions, including stabilization of cell-cell transmembrane cadherin complexes as well as regulation of actin dynamics associated with barrier function, lamellipodia formation, and cell migration via modulation of the activities of small GTPAses. One mechanism involves p120 catenin interaction with Rho GTPase activating protein (p190RhoGAP), leading to p190RhoGAP recruitment to cell periphery and local inhibition of Rho activity. In this study, we have identified a stretch of 23 amino acids within the C-terminal domain of p120 catenin as the minimal sequence responsible for the recruitment of p190RhoGAP (herein referred to as CRAD; catenin-RhoGAP association domain). Expression of the p120-catenin truncated mutant lacking the CRAD in endothelial cells attenuated effects of barrier protective oxidized phospholipid, OxPAPC. This effect was accompanied by inhibition of membrane translocation of p190RhoGAP, increased Rho signaling, as well as suppressed activation of Rac1 and its cytoskeletal effectors PAK1 (p21-activated kinase 1) and cortactin. Expression of p120 catenin-truncated mutant lacking CRAD also delayed the recovery process after thrombin-induced endothelial barrier disruption. Concomitantly, RhoA activation and downstream signaling were sustained for a longer period of time, whereas Rac signaling was inhibited. These data demonstrate a critical role for p120-catenin (amino acids 820-843) domain in the p120-catenin·p190RhoGAP signaling complex assembly, membrane targeting, and stimulation of p190RhoGAP activity toward inhibition of the Rho pathway and reciprocal up-regulation of Rac signaling critical for endothelial barrier regulation.
p120-catenin 是一种多功能细胞内蛋白,介导多种细胞功能,包括稳定细胞-细胞跨膜钙粘蛋白复合物,以及通过调节小 GTPases 的活性来调节与屏障功能、片状伪足形成和细胞迁移相关的肌动蛋白动力学。一种机制涉及 p120 钙粘蛋白与 Rho GTPase 激活蛋白(p190RhoGAP)的相互作用,导致 p190RhoGAP 募集到细胞膜边缘,并局部抑制 Rho 活性。在这项研究中,我们已经确定了 p120 钙粘蛋白 C 端结构域内的 23 个氨基酸长的片段是负责募集 p190RhoGAP 的最小序列(以下简称 CRAD;钙粘蛋白-RhoGAP 结合域)。在血管内皮细胞中表达缺乏 CRAD 的 p120-catenin 截断突变体,减弱了屏障保护氧化磷脂 OxPAPC 的作用。这种效应伴随着 p190RhoGAP 的膜转位抑制、Rho 信号的增加以及 Rac1 和其细胞骨架效应物 PAK1(p21 激活激酶 1)和 cortactin 的激活抑制。表达缺乏 CRAD 的 p120 钙粘蛋白截断突变体也延迟了凝血酶诱导的内皮屏障破坏后的恢复过程。同时,RhoA 激活和下游信号持续更长时间,而 Rac 信号被抑制。这些数据表明,p120-catenin(氨基酸 820-843)结构域在 p120-catenin·p190RhoGAP 信号复合物组装、膜靶向以及刺激 p190RhoGAP 活性以抑制 Rho 通路和反向上调 Rac 信号方面发挥关键作用,对于内皮屏障调节至关重要。